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Mutation analysis of HPS1, the gene mutated in
Hermansky-Pudlak syndrome, in patients with
isolated platelet dense-granule deficiency
Background and Objectives. Isolated platelet dense granule (PDG) deficiency is a het-
erogeneous disorder frequently found among patients with mild to moderate bleeding
diatheses. However, the molecular basis of this disorder is unknown. Genes involved in oth-
er rare bleeding disorders with associated reduction in the numbers of platelet dense-gran-
ules may play a role in isolated PDG deficiency. Among such genes, HPS1 is known to play
a key role in the genesis of PDG and as many as 18 different HPS1 mutations have been
identified in patients with Hermansky-Pudlak syndrome. Recently, we have identified
subjects with one HPS1 heterozygous mutation displaying significant reductions in PDG
without the clinical phenotype of Hermansky-Pudlak syndrome. This suggested that HPS1
mutations could be involved in isolated PDG deficiency.
Design and Methods. We sequenced all coding exons, and flanking intron regions of
HPS1 in 16 patients with mild to severe PDG deficiency, most of whom had mild bleed-
ing episodes. Nine patients reported a familial history of bleeding diathesis with PDG
deficiency. We also evaluated the prevalence of HPS1 variations in 215 controls. Trans-
mission electron microscopy was used to evaluate the number and morphology of PDG
from patients and selected controls.
Results. No patient with PDG deficiency carried severe mutations of the HPS1 gene. We
identified 6 previously described and 5 new polymorphisms in the HPS1 gene. Platelet elec-
tron microscopy in controls carrying these polymorphisms revealed that they did not sig-
nificantly modify the number or morphology of PDG. 
Interpretation and Conclusions. Mutations affecting the HPS1 gene play a minor role
in isolated PDG deficiency. These results support a molecular heterogeneity responsible
for the number and morphology of PDG.
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The key role of platelets in normal andpathological hemostasis and vascularremodelling is mediated by effector
molecules that platelets secrete at sites of
vascular injury. These molecules are con-
tained in dense granules and α granules
within the platelets. Platelet dense granules
(PDG) contain small molecules (nucleotides,
serotonin, catecholamines, ions and pyro-
phosphate) and have bound relevant adhe-
sive platelet glycoproteins (Ib-IX, IIb/IIIa, P-
selectin, and granulophysin).1 Accordingly,
these organelles play a key role in the ampli-
fication of platelet activation. Thus, a reduc-
tion in the number or contents of PDG will
impair platelet function, increasing the risk
of bleeding.
Disorders of platelet secretion are a con-
sequence of abnormalities affecting PDG.
These disorders are a relatively frequent
cause of mild to moderate bleeding diathe-
ses, characterized mainly by mucocutaneous
bleedings (epistaxis, menorrhagia, and easy
bruising).1 Patients with these disorders
show a mild to moderate prolonged bleed-
ing time, abnormal platelet secretion
induced by several platelet agonists, and
impaired platelet aggregation. The definitive
diagnosis is achieved by measuring signifi-
cant quantitative deficiencies of PDG and/or
of their electron-dense contents by means of
transmission electron microscopy.2 It is
known that 10-18% of patients with con-
genital abnormalities of platelet function
have PDG deficiency,3 but despite being a
relatively frequent disorder, the molecular
basis of isolated PDG deficiency is not
known.
Several rare and heterogeneous congeni-
tal bleeding disorders such as Chediak-
Higashi syndrome, Wiskott-Aldrich syn-
drome, and thrombocytopenia with absent
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radii, exhibit PDG deficiency, but Hermansky-Pudlak
syndrome is the most typically associated disease.4 Her-
mansky-Pudlak syndrome is a rare autosomal recessive
disorder manifested by occulocutaneous albinism, a
bleeding tendency, and in some cases ceroid-lipofuscin-
lysosomal storage disease. The storage pool defect aris-
es from defects in formation or trafficking of lysosomes
and related organelles, including melanosomes and
PDG.4 The molecular basis for Hermansky-Pudlak Syn-
drome is complex and heterogeneous, involving differ-
ent genetic loci.5 However, the majority of patients have
mutations in the HPS1 gene. As far as we know, 18
allelic mutations have been reported in HPS1, includ-
ing the North-West Puerto-Rican founder effect (a 16-
bp duplication within exon 15 identified in homozygo-
sis in about 400 patients with Hermansky-Pudlak syn-
drome from this country).4 Half of these mutations
affect exon 5 and 11, a fact which suggests two muta-
tional hot spots.6,7
The HPS1 gene has 20 exons, and it encodes a pro-
tein with 700 amino acids and a molecular mass of 79.3
KDa.8 Recent experiments have demonstrated that this
protein plays a key role in the genesis of multiple cyto-
plasmic organelles in different tissues and in particular
PDG.9 Finally, we have identified two relatives of a
Spanish patient with Hermansky-Pudlak syndrome who
carry only one HPS1 mutation (insC974) in a heterozy-
gous state; these individuals have a low number of PDG
and impaired platelet function without clinical symp-
toms.10
All these data suggest that the HPS1 gene might be
relevant in isolated storage pool deficiency.
Design and Methods
Patients
This study included 16 unrelated patients with mild
to severe deficit of PDG and mild bleeding episodes,
most of whom had been previously characterized.11 The
clinical features and laboratory results of these patients
are summarized in Table 1. Deficiency of PDG was
determined and characterized by transmission electron
microscopy. Table 1 also shows the number and mor-
phologic features of the PDG in these patients. Remark-
ably, nine patients had a familial history of PDG defi-
ciency. There was no clinical or biological evidence of
any condition or drug known to affect platelets. We
Table 1. Clinical, laboratory, transmission electron microscopy and genetic features of patients with single platelet
dense granule deficiency.
Age/ sex Plt1 Bleeding2 BT3 Aggregation4 PDG PDG FH7 HPS1 gene8
(min) (%)5 morphology6
1 8/F 400 EB, MB 9 ADP, Epi, Col 55 RC, FC Yes ISV5 G–35A+/- C636T (L212)+/-
2 20/M 200 MB, STO 11.5 Normal 50 FC Yes C636T (L212)+/- A1808G (Q603R)+/-
C1472T (P491R)+/-
3 26/M 170 MB 17 Epi 65 LED Yes C636T (L212) +/+ ISV16 A-15G+/-
4 64/F 300 MB 17 Normal 52 RC Yes No polymorphism
5 8/F 95 − 7 Normal 45 Normal Yes No polymorphism
6 32/F 350 EB, MB, STO 7.5 Normal 33 LED Yes C11T (V4A) +/- ISV16 A-15G+/-
C636T (L212) +/-
7 60/F 90 EB, MB >20 Epi, Col, AA 6 Normal No C636T (L212) +/- ISV16 A-15G+/-
ISV14 GG+7+8CT +/-3’UTR-C2115T +/-
8 26/F 140 EB, MB 15 Epi 70 RC, FC No C636T (L212) +/- A1808G (Q603R) +/-
C1472T (P491R) +/-
9 19/F 100 EB, STO 13,5 Epi 55 Normal No C11T (V4A) +/ - ISV16 A-15G+/-
C636T (L212) +/+ 10
10 42/F 275 EB, STO 8 Normal 55 Normal Yes ISV14 GG+7+8CT +/+ ISV16 A-15G+/+
11 10/F 450 EB 6 Normal 37 RC, FC No C636T (L212) +/ -ISV16 A-15G+/-
ISV14 GG+7+8CT +/-
12 31/M 110 − 11 Normal 50 FC No C636T (L212) +/+
13 20/F 320 EB, STO 9 Col 50 Normal Yes No polymorphism
14 44/F 165 EB, MB 6.5 Risto 20 Normal Yes ISV5 G–35A +/+ G847T (G283W) +/-
15 26/F 110 − 9 ND 60 Normal Yes C297T (T99) +/- C1472T (P491R) +/-
ISV14 GG+7+8CT +/-ISV16 A-15G+/-
A1808G (Q603R) +/-
16 6/F 450 EB, MB, STO 7 Normal 66 FC, EG Yes C636T (L212) +/-
1Plt: platelets ×109/L (microscopy counts); 2bleeding: EB: easy bruising; MB: mucous bleeding (epistaxis, menorrhagia, gingivorrhagia); STO: surgical, traumatic or
obstetric bleeding. 3BT: bleeding time (Ivy method). 4Impaired aggregation response to: Epi: epinephrine; AA: arachidonic acid; Col: collagen; Risto: ristocetin;
ND: not determined. 5Number of platelet dense granules per mm2 of platelet area, expressed as % of the mean normal numbers. 6Predominant dysmorphic traits of platelet
dense granules: RC: reduced solid core; FSC: fragmented solid core; EG: empty granule with no visible core; LED: low electron-density. 7FH: familial story of PDG deficiency.
8Genetic modifications identified in the HPS1 gene, indicating the nucleotide change and the affected codon (in brackets). The presence of the polymorphism in heterozygous
or homozygous state is also indicated (+/- and +/+, respectively).
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also evaluated the prevalence of HPS1 variations in 215
controls. Patients and controls gave their informed con-
sent to enter the study, which was performed accord-
ing to the declaration of Helsinki, as amended in Edin-
burgh in 2000.
Transmission electron microscopy
Platelet electron microscopy was used, as previously
described,11 to examine the number of dense granules
and their ultrastructural morphology in all patients with
PDG deficiency and in selected controls with genetic
modifications affecting the HPS1 gene. 
Venous blood samples were taken without anticoag-
ulant, immediately fixed in glutaraldehyde at 37°C, and
postfixed in osmium tetroxide in White’s buffer. The
number of PDG per µm2 of platelet area was counted.
The results were compared with those previously
obtained in a group of 15 healthy individuals.11 The mean
number of PDG per µm2 of these healthy individuals was
taken to be equivalent to 100%, and subject with val-
ues under 80% were considered to have PDG deficien-
cy. We also assessed PDG morphology.
DNA analysis
All coding exons of the HPS1 gene (exons 3-20), and
their flanking intron regions, were amplified by poly-
merase chain reaction (PCR) using previously described
primers and conditions.10 PCR products were purified
from 1.5% agarose gels using Ultraclean Gel Spin
(Mobio, Solana Beach, CA, USA). The sequencing reaction
was performed with an ABI Prism Big Dye Terminator
Cycle sequencing kit on an automated sequencer type
377 (Perkin-Elmer Applied Biosystems, Washington
Cheshire, UK), with forward and reverse primers used for
amplification. Genetic changes identified in the HPS1
gene were evaluated in controls by allele specific restric-
tion assay or single stranded conformational polymor-
phism (SSCP) (Table 2).
Results
HPS1 gene analysis in patients with isolated
PDG deficiency
Neither the insC974 mutation (frequently described
in patients with Hermansky-Pudlak syndrome of non-
Puerto Rican origin) nor other mutations affecting exon
11 (the main mutational hot spot of this gene), nor
mutations in exon 5 (a second mutational hot spot)6,7
were identified in patients with isolated PDG deficien-
cy. In brief, no patient carried severe mutations in the
HPS1 gene. However, our search did reveal 10
nucleotide changes according to the published
sequence of the HPS1 gene.12 Six of these changes were
previously described as common single nucleotide poly-
morphisms,7,12 but we also identified 4 unreported mod-
ifications: exon 3: C11T (Val4Ala); ISV5: G–35A; exon 7:
C636T (Leu 212); and exon 20: C2115T, affecting the 3'-
untranslated region of the gene, 12 positions after the
stop codon (according to the sequence of Bailin et al.,
nucleotide 1 begins at the first nucleotide).12 Table 1
shows the distribution of these polymorphisms. Finally,
the published cytosine ISV8 +29 is probably a mistake
or a rare genetic change identified by Bailin et al.,12
Table 2. Prevalence of HPS1 polymorphisms in 16 patients with single platelet dense granule deficiency, controls from
the same country, and other healthy populations. The amount of platelet dense granules of selected healthy individ-
uals is also indicated.
Polymorphism Method Controls Other populations1 Patients PDG deficiency
detection % (allele) PDG by TEM2 Caucasian % Asian % % (allele)
T11C (V4A) ASRA Bgl I 3.9% (0.038) Normal (N=2) ND ND 12.5% (0.063)
C297T (T99) Sequence ND ND 7.1% 40% 6.3% (0.031)
ISV5 G-35A ASRA Nde I 13.9% (0.081) Normal (N=2) ND ND 12.5% (0.094)
C636T (L212) ASRA Xho I 54.1% (0.311) Normal (N=1) ND ND 62.5% (0.406)
G847T (G283W) ASRA BseN I 9.5% (0.047) Normal (N=2) 7.1% 0 6.3% (0.031)
ISV11 T+13C SSCP 1% (0.010) Normal (N=1) 0 6.7% 0
insC974 SSCP 0 50% (relatives of ND ND 0
HPS patient N=2)3
ISV14 GG+7+8CT Sequence ND ND 42.9% 63.3% 25.0% (0.156)
C1472T (P491R) Sequence ND 21.4% 40% 18.8% (0.094)
A1808G (Q603R) ASRA Msp I 14.1% (0.070) Normal (N=2) 21.4% 40% 18.8% (0.094)
ISV16 A-15G Sequence ND ND 42.6% 63.3% 43.8% (0.250)
C2115T ASRA Pst I 1% (0.005) Normal (N=2) ND ND 6.3% (0.031)
1Data from Bailin et al.11 2Number of platelet dense granules determined by transmission electron microscopy. N: number of healthy subjects investigated.
3Data from González-Conejero et al.
9
ASRA: allelic specific restriction assay. ND: not determined. HPS: Hermansky-Pudlak syndrome.
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because all sequenced patients and two controls dis-
played adenine in a homozygous state at this position.
We did not identify any of the other polymorphisms
described in the HPS1 gene in our patients.
Prevalence of HPS1 genetic modifications in
controls
In order to determine whether genetic changes iden-
tified in the HPS1 gene are rare mutations or common
polymorphisms, we investigated their prevalence in the
control group. We only studied those modifications that
were identified by restriction assay or SSCP. Thus, C297T
(Thr99), ISV14 GG+7+8CT, and ISV16 A-15G were not
evaluated in controls. The C1472T (Pro491Arg) was not
directly studied, but this polymorphism seems to be
strongly linked to the A1808G (Gln603Arg), as these
polymorphisms displayed identical frequency in different
populations (Table 2), and we detected complete linkage
disequilibrium (Table 1). Mutations affecting exon 11,
the main HPS1 mutational hot-spot, were also evaluat-
ed in controls by SSCP.10 Table 2 summarizes these
results. We did not observe the insC974 mutation in con-
trols, but we identified one additional polymorphism
(ISV11 T+13C ) that was previously reported to be pres-
ent in 3% of the Asian population, but not in the Cau-
casian population.12 The frequency of HPS1 polymor-
phisms was similar among patients with isolated PDG
deficiency and among controls (Table 2).
Transmission electron microscopy of platelets
from controls carrying HPS1 polymorphisms
In order to test the role of HPS1 polymorphisms in
PDG deficiency, we studied the dense granules in
platelets from healthy subjects carrying the studied poly-
morphisms. No HPS1 polymorphism was significantly
associated with severe reduction in the number of PDG
or changes in PDG morphology (Table 2).
Discussion
Platelet dense granule deficiency is frequently
observed among patients with congenital abnormalities
of platelet function.3 The notable family clustering of
PDG deficiency supports the role of genetic factors in
this disorder.
Mutations affecting different genes have been iden-
tified in patients or animal models with rare syndromes
associated with PDG deficiency such as Chediak-Higashi
syndrome, Wiskott-Aldrich syndrome, thrombocytopenia
with absent radii, or Hermansky-Pudlak syndrome,4
although, as far as we know, no genetic defect has been
implicated in isolated PDG deficiency. All genes involved
in organogenesis of PDG and those involved in disorders
with PDG deficiency are candidates to play a role in iso-
lated PDG deficiency. We studied the HPS1 gene because
of the key role of this gene in the organogenesis of PDG,
its relevance in Hermansky-Pudlak syndrome, the num-
ber of mutations identified, and the identification of
carriers of HPS1 mutations without clinical signs but
with a significant reduction in the number of PDG.4-10
In fact, we speculated that mutational hot-spots of
the HPS1 gene, specifically the insC974 mutation, com-
mon among non-Puerto Rican patients with Herman-
sky-Pudlak syndrome,6,7,9,13 could be present in the gen-
eral population and might be responsible for PDG defi-
ciency. However, we did not detect this mutation or oth-
er HPS1 mutations in either the general population or
patients with isolated PDG deficiency. In accordance
with this, a study sequenced the HPS1 gene in one
patient with isolated PDG deficiency did not find any
significant mutations.13 The HPS1 polymorphisms iden-
tified in our study played no significant role in the num-
ber or morphologic features of the PDG. These data
strongly suggest that the HPS1 gene plays only a minor
role in isolated PDG deficiency.
The synthesis and/or processing of melanosomes, lyso-
somes and PDG are under a common and complex
genetic control. In the mouse, at least 15 genes are
involved in a phenotype resembling the human Her-
mansky-Pudlak syndrome.14 The disease is likewise
genetically heterogeneous in humans. Thus far, muta-
tions in 7 orthologous genes have been found in patients
with Hermansky-Pudlak syndrome.15 All these genes are
candidates to be involved in isolated PDG deficiency.
Mutations affecting HPS1 and 4 have been identified in
patients with severe forms of Hermansky-Pudlak syn-
drome, always including hypopigmentation. Patients
with HPS2 (carrying mutations in the β-3A subunit of
adaptor complex-3 (AP-3) always have neutropenia.
However, patients with defects in HPS 3, 5 and 6 (and
probably also HPS7) have relatively mild clinical pheno-
types, often with no apparent hypopigmentation, but
only bleeding problems.16 According to these data and
our results, HPS 3, 5 and 6 genes are perfect candidates
to be screened in cases with isolated PDG deficiency.
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